Table of Contents
2019-2024 Global Precision Cancer Tests Market Report (Status and Outlook)
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Precision Cancer Tests Market Size 2014-2024
2.1.2 Precision Cancer Tests Market Size CAGR by Region
2.2 Precision Cancer Tests Segment by Type
2.2.1 Imaging
2.2.2 In Vitro Diagnostic
2.2.3 Others
2.3 Precision Cancer Tests Market Size by Type
2.3.1 Global Precision Cancer Tests Market Size Market Share by Type (2014-2019)
2.3.2 Global Precision Cancer Tests Market Size Growth Rate by Type (2014-2019)
2.4 Precision Cancer Tests Segment by Application
2.4.1 Cancer Research Centers
2.4.2 Cancer Hospital
2.4.3 Surgical Centers
2.4.4 Clinics
2.4.5 Others
2.5 Precision Cancer Tests Market Size by Application
2.5.1 Global Precision Cancer Tests Market Size Market Share by Application (2014-2019)
2.5.2 Global Precision Cancer Tests Market Size Growth Rate by Application (2014-2019)
3 Global Precision Cancer Tests by Players
3.1 Global Precision Cancer Tests Market Size Market Share by Players
3.1.1 Global Precision Cancer Tests Market Size by Players (2017-2019)
3.1.2 Global Precision Cancer Tests Market Size Market Share by Players (2017-2019)
3.2 Global Precision Cancer Tests Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Precision Cancer Tests by Regions
4.1 Precision Cancer Tests Market Size by Regions
4.2 Americas Precision Cancer Tests Market Size Growth
4.3 APAC Precision Cancer Tests Market Size Growth
4.4 Europe Precision Cancer Tests Market Size Growth
4.5 Middle East & Africa Precision Cancer Tests Market Size Growth
5 Americas
5.1 Americas Precision Cancer Tests Market Size by Countries
5.2 Americas Precision Cancer Tests Market Size by Type
5.3 Americas Precision Cancer Tests Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Precision Cancer Tests Market Size by Countries
6.2 APAC Precision Cancer Tests Market Size by Type
6.3 APAC Precision Cancer Tests Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Precision Cancer Tests by Countries
7.2 Europe Precision Cancer Tests Market Size by Type
7.3 Europe Precision Cancer Tests Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Precision Cancer Tests by Countries
8.2 Middle East & Africa Precision Cancer Tests Market Size by Type
8.3 Middle East & Africa Precision Cancer Tests Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Precision Cancer Tests Market Forecast
10.1 Global Precision Cancer Tests Market Size Forecast (2019-2024)
10.2 Global Precision Cancer Tests Forecast by Regions
10.2.1 Global Precision Cancer Tests Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Precision Cancer Tests Forecast by Type
10.8 Global Precision Cancer Tests Forecast by Application
11 Key Players Analysis
11.1 Abbott
11.1.1 Company Details
11.1.2 Precision Cancer Tests Product Offered
11.1.3 Abbott Precision Cancer Tests Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Abbott News
11.2 BD
11.2.1 Company Details
11.2.2 Precision Cancer Tests Product Offered
11.2.3 BD Precision Cancer Tests Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 BD News
11.3 Bio-Rad
11.3.1 Company Details
11.3.2 Precision Cancer Tests Product Offered
11.3.3 Bio-Rad Precision Cancer Tests Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 Bio-Rad News
11.4 Cynvenio Biosystems
11.4.1 Company Details
11.4.2 Precision Cancer Tests Product Offered
11.4.3 Cynvenio Biosystems Precision Cancer Tests Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Cynvenio Biosystems News
11.5 Foundation Medicine
11.5.1 Company Details
11.5.2 Precision Cancer Tests Product Offered
11.5.3 Foundation Medicine Precision Cancer Tests Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 Foundation Medicine News
11.6 Genomic Health
11.6.1 Company Details
11.6.2 Precision Cancer Tests Product Offered
11.6.3 Genomic Health Precision Cancer Tests Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 Genomic Health News
11.7 Illumina
11.7.1 Company Details
11.7.2 Precision Cancer Tests Product Offered
11.7.3 Illumina Precision Cancer Tests Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Illumina News
11.8 Myriad Genetics
11.8.1 Company Details
11.8.2 Precision Cancer Tests Product Offered
11.8.3 Myriad Genetics Precision Cancer Tests Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 Myriad Genetics News
11.9 NanoString Technologies
11.9.1 Company Details
11.9.2 Precision Cancer Tests Product Offered
11.9.3 NanoString Technologies Precision Cancer Tests Revenue, Gross Margin and Market Share (2017-2019)
11.9.4 Main Business Overview
11.9.5 NanoString Technologies News
11.10 QIAGEN
11.10.1 Company Details
11.10.2 Precision Cancer Tests Product Offered
11.10.3 QIAGEN Precision Cancer Tests Revenue, Gross Margin and Market Share (2017-2019)
11.10.4 Main Business Overview
11.10.5 QIAGEN News
11.11 Randox Laboratories
11.12 Roche
11.13 Philips
11.14 Thermo Fisher Scientific
12 Research Findings and Conclusion
